IF: 1.578
Cite Score:
1.45
THOMSON REUTERS - SCOPUS

Potential Activity of Camel Milk-Amylase and Lactoferrin against Hepatitis C Virus Infectivity in HepG2 and Lymphocytes

AUTHORS

Esmail M El-Fakharany 1 , Ashraf Tabll 1 , Abeer Abd El Wahab 1 , Bakry M Haroun 2 , El-Rashdy M Redwan 3 , *

AUTHORS INFORMATION

1 Antibody Laboratory, Protein Research Department, Genetic Engineering and Biotechnology Research Institute, Mubarak City for Scientific Research and Technology Applications, Egypt

2 Botany and Microbiology Department, Faculty of Science, Al-Azhar University, Egypt

3 Antibody Laboratory, Protein Research Department, Genetic Engineering and Biotechnology Research Institute, Mubarak City for Scientific Research and Technology Applications, redwan1961@yahoo.com, Egypt

How to Cite: El-Fakharany E, Tabll A, Wahab A, Haroun B, Redwan E. Potential Activity of Camel Milk-Amylase and Lactoferrin against Hepatitis C Virus Infectivity in HepG2 and Lymphocytes, Hepat Mon. Online ahead of Print ; 8(2):101-109.

ARTICLE INFORMATION

Hepatitis Monthly: 8 (2); 101-109
Article Type: Research Article
Received: March 6, 2008
Accepted: June 6, 2008

Crossmark

CHEKING

READ FULL TEXT
Abstract

Background and Aims: To exploring which camel milk proteins, have the ability to inhibit and/or blocking the hepatitis C virus (HCV) entry and replication inside the cells system.

Methods: Using human peripheral blood mononuclear cells (PBMCs) and hepG2 cells system, three experiments were setup: 1) cells treated with amylase or lactoferrin then infected with HCV; 2) HCV treated with amylase or lactoferrin then used to infect the cells; and 3) HCV infected cells were treated with amylase or lactoferrin. RNA was extracted, RT-PCR and nested PCR were run, in addition to immune-staining the cells to localize the viral molecule within the cells foci.

Results: Camel milk-amylase and lactoferrin were in vitro tested the ability to inhibit the HCV entry and replication inside the human peripheral blood and hepG2. Amylase could not able to inhibit nor blocking the viral replication. However, lactoferrin demonstrate a clear ability to inhibit the viral entry into both cells system when pre-interact with the virus, but fault to protect the cells before infection. The virus replication inside the cells was completely blocked only when the infected cells were treated with lactoferrin.

Conclusions: Camel lactoferrin was demonstrated a remarked in vitro ability to completely inhibit the HCV entry into PBMC, hepG2 and replication inside those cells system.

Keywords

Camel Milk Amylase Lactoferrin Hepatitis C Inhibition In Vitro Assay

© 0, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.

Full Text

Full text is available in PDF

COMMENTS

LEAVE A COMMENT HERE: